slotkoers
Korea S.E.
00:00:00 26-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.423
KRW
|
+0,92%
|
|
-7,84%
|
-23,16%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
82.235
|
204.207
|
166.501
|
87.860
|
80.681
|
Bedrijfswaarde
1 |
91.484
|
186.810
|
151.796
|
97.147
|
71.704
|
K/w-verhouding
|
-5,46
x
|
-28,4
x
|
-15,7
x
|
-2,26
x
|
-1,78
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
20,1
x
|
4,47
x
|
5,49
x
|
5,45
x
|
15
x
|
Bedrijfswaarde/omzet
|
22,3
x
|
4,09
x
|
5,01
x
|
6,03
x
|
13,4
x
|
Bedrijfswaarde/EBITDA
|
-9,12
x
|
35,6
x
|
-18
x
|
-4,21
x
|
-4,06
x
|
Bedrijfswaarde/FCF
|
-
|
-7.228.557
x
|
-16.703.865
x
|
78.957.737
x
|
-4.372.895
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
78,3
x
|
3,65
x
|
3,19
x
|
4,97
x
|
2,18
x
|
Aantal aandelen (in duizenden)
|
14.641
|
21.782
|
21.956
|
21.965
|
43.564
|
Referentieprijs
2 |
5.617
|
9.375
|
7.583
|
4.000
|
1.852
|
Datum van publicatie
|
19/03/21
|
19/03/21
|
21/03/22
|
22/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
4.098
|
45.672
|
30.302
|
16.111
|
5.367
|
EBITDA
1 |
-10.036
|
5.242
|
-8.419
|
-23.075
|
-17.673
|
Bedrijfsresultaat (EBIT)
1 |
-11.747
|
3.466
|
-10.859
|
-25.922
|
-19.983
|
Operationele Marge
|
-286,65%
|
7,59%
|
-35,83%
|
-160,89%
|
-372,3%
|
Resultaat voor belastingen (EBT)
1 |
-14.655
|
-5.789
|
-10.598
|
-38.932
|
-25.808
|
Nettowinst (verlies)
1 |
-14.632
|
-5.776
|
-10.575
|
-38.893
|
-25.774
|
Nettomarge
|
-357,04%
|
-12,65%
|
-34,9%
|
-241,4%
|
-480,2%
|
WPA
2 |
-1.028
|
-330,0
|
-482,5
|
-1.772
|
-1.042
|
Free Cash Flow
|
-
|
-25.843
|
-9.088
|
1.230
|
-16.397
|
FCF-marge
|
-
|
-56,58%
|
-29,99%
|
7,64%
|
-305,5%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19/03/21
|
19/03/21
|
21/03/22
|
22/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
9.249
|
-
|
-
|
9.287
|
-
|
Nettokaspositie
1 |
-
|
17.397
|
14.704
|
-
|
8.977
|
Hefboom (schuld/ebitda)
|
-0,9216
x
|
-
|
-
|
-0,4025
x
|
-
|
Free Cash Flow
|
-
|
-25.843
|
-9.088
|
1.230
|
-16.397
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-20,3%
|
-19,6%
|
-111%
|
-95,6%
|
ROA (netto-inkomsten/totale activa)
|
-
|
4,51%
|
-8,5%
|
-22,2%
|
-21%
|
Totale activa
1 |
-
|
-127.977
|
124.378
|
175.471
|
122.615
|
Nettoactief per aandeel
2 |
71,70
|
2.570
|
2.381
|
806,0
|
849,0
|
Cashflow per aandeel
2 |
675,0
|
958,0
|
1.085
|
259,0
|
215,0
|
Capex
1 |
1.338
|
5.761
|
2.841
|
1.625
|
385
|
Capex/omzet
|
32,66%
|
12,61%
|
9,38%
|
10,08%
|
7,18%
|
Datum van publicatie
|
19/03/21
|
19/03/21
|
21/03/22
|
22/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -23,16% | 44,53 mln. | | -54,19% | 2,26 mld. | | +19,59% | 1,89 mld. | | -8,65% | 1,52 mld. | | +18,40% | 1,19 mld. | | -24,23% | 871 mln. | | +1,77% | 781 mln. | | -34,22% | 750 mln. | | -29,46% | 591 mln. | | +18,16% | 560 mln. |
Medisch diagnose- & testmateriaal
|